Microglia (green) derived from human stem cells by members of the Kampmann lab.
Image by Olivia Teter, Kampmann lab, UCSF
The discovery of how to shift damaged brain cells from a diseased state into a healthy one presents a potential new path to treating Alzheimer’s and other forms of dementia, according to a new study from researchers at UC San Francisco.
The research focuses on microglia, cells that stabilize the brain by clearing out damaged neurons and the protein plaques often associated with dementia and other brain diseases.
These cells are understudied, despite the fact that changes in them are known to play a significant role Alzheimer’s and other brain diseases, said Martin Kampmann, PhD, senior author on the study, which appears Aug. 11 in Nature Neuroscience.
“Now, using a new CRISPR method we developed, we can uncover how to actually control these microglia, to get them to stop doing toxic things and go back to carrying out their vitally important cleaning jobs,” he said. “This capability presents the opportunity for an entirely new type of therapeutic approach.”
Leveraging the Brain’s Immune System
Most of the genes known to increase the risk for Alzheimer’s disease act through microglial cells. Thus, these cells have a significant impact on how such neurodegenerative diseases play out, said Kampmann.
Microglia act as the brain’s immune system. Ordinary immune cells can’t cross the blood-brain barrier, so it’s the task of healthy microglia to clear out waste and toxins, keeping neurons functioning at their best. When microglia start losing their way, the result can be brain inflammation and damage to neurons and the networks they form.
Under some conditions, for example, microglia will start removing synapses between neurons. While this is a normal part of brain development in a person’s childhood and adolescent years, it can have disastrous effects in the adult brain.
Over the past five years or so, many studies have observed and profiled these varying microglial states but haven’t been able to characterize the genetics behind them.
Kampmann and his team wanted to identify exactly which genes are involved in specific states of microglial activity, and how each of those states are regulated. With that knowledge, they could then flip genes on and off, setting wayward cells back on the right track.
From Advanced Genomics to a Holy Grail
Accomplishing that task required surmounting fundamental obstacles that have prevented researchers from controlling gene expression in these cells. For example, microglia are very resistant to the most common CRISPR technique, which involves getting the desired genetic material into the cell by using a virus to deliver it.
To overcome this, Kampmann’s team coaxed stem cells donated by human volunteers to become microglia and confirmed that these cells function like their ordinary human counterparts. The team then developed a new platform that combines a form of CRISPR, which enables researchers to turn individual genes on and off – and which Kampmann had a significant hand in developing – with readouts of data that indicate functions and states of individual microglia cells.
This capability presents the opportunity for an entirely new type of therapeutic approach.
Through this analysis, Kampmann and his team pinpointed genes that affect the cell’s ability to survive and proliferate, how actively a cell produces inflammatory substances, and how aggressively a cell prunes synapses.
And because the scientists had determined which genes control those activities, they were able to reset the genes and flip the diseased cell to a healthy state.
Armed with this new technique, Kampmann plans to investigate how to control the relevant states of microglia, by targeting the cells with existing pharmaceutical molecules and testing them in preclinical models. He hopes to find specific molecules that act on the genes necessary to nudge diseased cells back to a healthy state.
Kampmann said that once the right genes are flipped, it’s likely that the “repaired,” microglia will resume their responsibilities, removing plaques associated with neurodegenerative disease and protecting synapses rather than taking them apart.
“Our study provides a blueprint for a new approach to treatment,” he said. “It’s a bit of a holy grail.”
Original Article: Reprogramming the Brain’s Cleaning Crew to Mop Up Alzheimer’s Disease
More from: University of California San Francisco
The Latest Updates from Bing News
Go deeper with Bing News on:
Synthetic molecular motors
- Team resolves molecular switching behavior of azonium compounds for light-controlled drugs
Molecules that change shape under the influence of light can be used as switches in biomedical applications, for instance to inhibit an enzyme. An international team of researchers, including chemists ...
- ‘Simplistic’ molecular motor avoids complex synthesis
A new molecular motor, which is much simpler than many before it, can carry cargo across a surface without missteps or changes in direction. The simple motor avoids the complex synthesis associated ...
- Physicists solve mysteries of microtubule movers
The research team focused on one of the most common examples of active matter, a suspension of self-propelled particles, such as bacteria or synthetic ... is driven by molecular motors powered ...
- Physicists Solve Mysteries of Microtubule Movers
School of Physics graduate researcher Matthew Golden is the study's lead author. Co-authors are graduate researcher Jyothishraj Nambisan and Alberto Fernandez-Nieves, professor in the Department of ...
- Valvoline™ Global Operations launches new full synthetic 4-stroke motor oils
Formulated for the demanding needs of powersport vehicles and boats, Valvoline Full Synthetic 4-Stroke Motor Oil provides superior protection and performance in all conditions and climates.
Go deeper with Bing News on:
- Scientists reveal cellular changes unique to early Alzheimer's disease
Most Alzheimer's disease research on human brain tissue has studied postmortem samples, making it difficult for scientists to discern the earliest events in the brain that might have triggered the ...
- Fatty Foods Influence Memory Formation
Their earlier research on aging rats established a link between processed food diets, brain inflammation, and signs of memory loss.
- Stem cell transplant refreshes brain cells to treat Alzheimer's in mice
Scientists at Stanford Medicine have tested a new potential treatment for Alzheimer’s disease in mice. The therapy involves transplanting blood stem cells from healthy mice into those with the disease ...
- Vigil Neuroscience Receives Positive Opinion from European Medicines Agency on Orphan Drug Designation for VGL101 for the Treatment of ALSP
Receiving a positive opinion for orphan drug designation for VGL101 in the EU is a tremendous achievement in our efforts to develop a therapy for individuals living with ALSP, which affects ...
- Study shows stem cell therapy can be helpful in reducing Alzheimer's symptoms
Scientists at Stanford University have successfully transplanted stem cells into mice, resulting in a reduction of brain abnormalities associated with Alzheimer's disease. The researchers replaced ...